Fibermetrix Sas

Fibermetrix delivers advanced dosimetry solutions focused on real-time radiation dose measurement and monitoring, significantly enhancing safety in radiation-exposed environments across various industries. Fibermetrix specializes in providing real-time dosimetry solutions. The company is headquartered in France and was founded by professionals with experience in radiation safety technology. In April 2022, Fibermetrix successfully raised EUR 500,000 in venture funding, contributing to the total amount raised of EUR 500,000.

The investment was led by WiCap GmbH, with participation from Capital Grand Est. The most recent deal exemplifies the company's active engagement with investors to support its growth strategy. Fibermetrix specializes in advanced dosimetry solutions, focusing on real-time radiation dose measurement and monitoring. Their patented measurement technology utilizes scintillating fiber for ultra-fast dose measurement, delivering instant feedback through a sophisticated telemonitoring interface.

Their products serve healthcare facilities, research institutions, and industries requiring stringent radiation safety, marketed primarily in Europe and select international regions. In 2015, Fibermetrix reported a revenue of EUR 555,000. The company operates on a subscription-based revenue model, offering access to their monitoring systems starting from EUR 180 per month. This ensures continuous service and support for clients, including hospitals and research entities, integrating advanced monitoring tools into their operations.

Fibermetrix plans to expand its market presence by designing new products, aiming to launch innovative solutions designed to enhance real-time dosimetry capabilities by mid-2023. The company intends to penetrate new markets outside of Europe, specifically targeting North America and Asia by 2024. The recent funding of EUR 500,000 will be allocated toward product development and market expansion initiatives, supporting the company's strategic objectives.